Clearwater Analytics Holdings, Inc. (CWAN) Q3 2025 Earnings Call Transcript
Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
Overview
The earnings call reveals strong financial performance with a 75%-76% YoY revenue growth and a consistent EBITDA margin of 32%. The company is focusing on margin expansion, debt reduction, and integrated platform development. The Q&A highlights optimism about future growth, particularly in ARR and new pricing models. While there were some vague responses, the overall sentiment, including a robust market strategy and positive financial metrics, suggests a positive stock price movement. Given the market cap, the stock is likely to react positively, but not extremely, suggesting a 2%-8% increase.
Key Financial Performance
Revenue $205.1 million, a 77% year-on-year growth. The growth was driven by the integration of acquisitions and strong performance in the hedge fund market.
Annualized Recurring Revenue (ARR) $807.5 million, up 77% year-over-year. This reflects the durability and predictability of the business model, with organic ARR improving to $534.4 million.
Adjusted EBITDA $70.7 million, up from $58.3 million in Q2 and an 84% year-over-year growth. The margin improved to 34.5% from 32.1% in Q2, driven by operational efficiencies and integration of acquisitions.
Gross Revenue Retention (GRR) 98%, consistent with historical performance, attributed to strong client retention and operational excellence.
Gross Margin 78.5%, flat year-over-year but achieved earlier than the 2027 target, driven by integration efficiencies and the use of Generative AI.
Net Revenue Retention (NRR) 108%, slightly down from 110% in Q2 due to lower contributions from AUM growth and asset-based upsells.
Core Clearwater Growth 21% year-to-date over last year, showing resilience and strong performance.
Enfusion Growth 12% expected growth for the year, with continued booking execution in Q2 and Q3.
EBITDA Margin 34.5%, a 140 basis point improvement compared to Q3 2024, reflecting efficiency gains and successful integration of lower-margin businesses.
You have reached the limit. Sign up to access full content
Get started
Operating Highlights
Generative AI: CWAN has integrated Generative AI into its operations, achieving significant gross margin improvements. The platform hosts over 800 AI agents, managing $10 trillion in institutional assets. Clients have seen 90% reductions in manual reconciliation, 80% faster regulatory reporting, and 50% faster financial close cycles.
Integrated Platform Development: CWAN is developing a single security master, a comprehensive data platform, a single interaction layer, and a single interchange layer, expected to launch in H2 2026 and early 2027.
Total Addressable Market (TAM): CWAN's TAM has grown to $23 billion, driven by globalization, alternative assets, and regulatory needs. The company is leveraging its competitive position to capture market share.
Geographic Expansion: CWAN has expanded its global capabilities, with wins in North America, Europe, Asia, and Latin America. Notable clients include Texas Treasury Safekeeping Trust and the Latin American Reserve Fund.
Revenue and ARR Growth: Q3 revenue reached $205.1 million, a 77% YoY growth. ARR also grew 77% YoY to $807.5 million, showcasing business durability.
Margin Improvements: Gross margin reached 78.5%, hitting 2027 targets early. Adjusted EBITDA margin improved to 34.5%, driven by operational efficiencies and GenAI adoption.
Acquisitions and Integration: CWAN successfully integrated Enfusion, Beacon, and Bistro, achieving 77% revenue growth and 84% EBITDA growth YoY. The acquisitions expanded TAM and enhanced cross-selling opportunities.
Cross-Selling Initiatives: Cross-selling efforts have begun, with a 70% increase in bookings for core cross-sell modules. This is expected to drive growth in Q4 2025 and beyond.
You have reached the limit. Sign up to access full content
Get started
Risk or Challenges
Market Conditions: The company faces challenges from the competitive landscape, despite its strong positioning. The market's demand environment may fluctuate, impacting growth opportunities.
Regulatory Hurdles: The increasing complexity related to regulatory and compliance needs poses a challenge for the company to continuously adapt its technology and solutions.
Supply Chain Disruptions: No explicit mention of supply chain disruptions was made in the transcript.
Economic Uncertainties: Economic conditions, such as fluctuations in AUM (Assets Under Management) growth, have impacted net revenue retention rates, which could affect financial performance.
Strategic Execution Risks: The integration of acquired businesses (Enfusion, Beacon, Bistro) presents risks, including achieving margin synergies and aligning commercial models. Additionally, the company’s ambitious plans for Generative AI and platform unification by 2026-2027 carry execution risks.
You have reached the limit. Sign up to access full content
Get started
Guidance & Outlook
Revenue Projections: For Q4 2025, total revenue is expected to be $216 million to $217 million, representing a year-over-year growth rate of 71% to 72%. For the full year 2025, total revenue is projected to be between $730 million and $731 million, representing a year-over-year growth rate of approximately 62%.
EBITDA Projections: Fourth quarter EBITDA is expected to be $73 million, representing an adjusted EBITDA margin of 34%. Full year 2025 EBITDA is projected to be $247 million, with a full year margin of 34%, which is 180 basis points better than 2024 margins.
Growth Expectations: The company expects cross-selling to power growth in Q4 2025 and in 2026 and beyond. Growth plans include expanding in insurance, asset management, and asset owners, as well as executing opportunities across geographies, markets, and products.
Generative AI Impact: Generative AI is expected to continue driving gross margin improvements and operational efficiencies. The company plans to bring new integrated AI-driven solutions to market in H2 2026 and early 2027.
Platform Development: The company is working on building an integrated, open, modular, and extensible front-to-back platform, with key components expected to be launched in H2 2026 and early 2027.
Market Position and TAM: The total addressable market (TAM) has grown to approximately $23 billion, with significant opportunities across geographies and markets. The company aims to leverage its competitive position to capture market share.
You have reached the limit. Sign up to access full content
Get started
Shareholder Return Plan
Share Repurchase: The company repurchased more than 800,000 shares of CWAN stock during the quarter. This was enabled by strong EBITDA performance, which provided the financial flexibility to execute the share buyback program.
You have reached the limit. Sign up to access full content
Get started
Key Q&A
Q:Can you provide an update on the segments of the market showing elevated strength and the receptivity to the unified platform vision?
A:Sandeep Sahai highlighted that alternatives (LPx, MLx, Risk, and Prism) grew 70% year-on-year in bookings and continue to have an expanded pipeline. Risk offerings, particularly after acquiring Beacon, have seen quicker-than-expected 7-figure deals. Hedge funds performed well in Q2 and Q3 and are forecasted to do well in Q4 after a slow Q1. Insurance expansion in Europe is also a positive development.
Q:Can you reconcile the 17% core ARR growth in the quarter with the implied performance of the core business growing steadily at 20%?
A:James Cox explained that while Q1 was slower, Q2 and Q3 showed strong performance, and the pipeline and bookings indicate sustained momentum. The timing of revenue and ARR recognition from large deals can create discrepancies, but the overall business is performing well.
Q:How should we think about ARR growth of 17% for the core business and its dynamics looking into 2026?
A:Sandeep Sahai noted that larger deals create lumpiness in ARR when they come online, but over time, ARR growth should align with core business growth. ARR grew 77% year-on-year, and Q3 had $22 million in ARR growth. Acceleration is expected in Q4.
Q:Is it possible to give an estimate of organic ARR for the full year?
A:James Cox stated that they will provide this estimate during the February call.
Q:How are you thinking about the timing and magnitude of potential uplift in 2026 from the Enfusion pricing and contract structure revision?
A:James Cox mentioned that the new pricing model will roll out for new clients starting January 1, 2026, and will be implemented for existing clients throughout 2026. Sandeep Sahai added that the goal is to align value with pricing, similar to a previous program with Clearwater, and expects the process to be completed by the end of 2026.
Q:What is the trade-off between delivering material EBITDA upside and allocating resources to speed up revenue go-live?
A:Sandeep Sahai emphasized focusing on technology, particularly generative AI, to accelerate onboarding and achieve sustained results rather than hiring more staff. The company is considering additional marketing spend for 2026.
Q:Can you comment on the run rates for Enfusion and its potential acceleration in 2026?
A:Sandeep Sahai stated that the Enfusion platform is robust and scalable, with dedicated teams focusing on hedge funds. Growth is expected to accelerate beyond 12% with the new commercial model and additional product offerings like risk, managed services, and client reporting.
Q:Is the functionality of Bistro applicable to all insurance carrier customers, and when will contracts be secured?
A:Sandeep Sahai explained that Bistro enhances visualization and reporting for alternatives and is strategically important. While it is not yet driving growth, integration with the Clearwater environment is underway, and traction is expected in 2026.
Q:Can you quantify the performance of the international business relative to the overall business?
A:James Cox noted that the split between ARR by geography is consistent with Q2, as shown in their investor deck.
Q:How has core Clearwater retention trended in the quarter?
A:James Cox stated that metrics provided are across the entire business, with AUM and upsell mostly within the core Clearwater business.
Q:Is there a particular end market or geography where customers are adopting the combined company assets first?
A:Sandeep Sahai highlighted asset management as the largest booking industry year-to-date, with significant traction in risk-related offerings and alternatives.
Q:Are there any changes in competitor behavior due to Clearwater's transformation?
A:Sandeep Sahai noted increased client and analyst interest, emphasizing Clearwater's competitive position and ability to deploy generative AI effectively.
Q:What is the current penetration and adoption for LPx and other modules, and what is the white space for more adoption?
A:James Cox mentioned strong progress with LPx adoption across the insurance client base, with plans to expand to other segments. Sandeep Sahai added that ARR from alternatives, risk, and other offerings could match accounting ARR over time.
Q:How is the integration of Clearwater, Enfusion, and Beacon progressing, and what are the takeaways for the unified platform?
A:Sandeep Sahai stated that integration is proceeding well, with the unified platform expected to go live by mid-next year.
Q:How much of new bookings is driven by alternative assets today versus a couple of years ago?
A:Sandeep Sahai noted that alternatives now account for over 35% of bookings, up from 24-25% a few years ago, and this share is expected to grow further.
Q:What is the pricing model and go-to-market strategy for generative AI, and what insights are there from early adopters?
A:Sandeep Sahai explained that generative AI is not sold separately but enhances products like Prism and internal processes. It has improved gross margins and client reporting, with strong engagement since the Connect Conference.
Q:Review of Unclear Management Responses
A:Management avoided providing a direct estimate of organic ARR for the full year, deferring it to the February call. Additionally, while discussing the Bistro solution, they acknowledged its strategic importance but did not provide specific timelines or metrics for its adoption.
You have reached the limit. Sign up to access full content
Get started
Earnings Word Cloud
The most frequently occurring keywords in this quarter's earning call
AWS
CWAN Financial
CWAN GenAI
Enfusion
GenAI agent
GenAI margin
LPx
Number TAM
Number margin
UK
achievement
asset manager
asset owner
avenue
bank
breadth
business
contribution AUM
driver
element product
fund market
geography market
government
hedge fund
institution
layer
margin basis
market share
need
offering
profitability profile
risk valuation
run
source
state
strength
target
valuation capability
word
year investment
CWAN Transcript
Clearwater Analytics Holdings, Inc. (CWAN) Q3 2025 Earnings Call Transcript
Positive11-6
The earnings call reveals strong financial performance with a 75%-76% YoY revenue growth and a consistent EBITDA margin of 32%. The company is focusing on margin expansion, debt reduction, and integrated platform development. The Q&A highlights optimism about future growth, particularly in ARR and new pricing models. While there were some vague responses, the overall sentiment, including a robust market strategy and positive financial metrics, suggests a positive stock price movement. Given the market cap, the stock is likely to react positively, but not extremely, suggesting a 2%-8% increase.
Clearwater Analytics Holdings, Inc. (CWAN) Q4 2023 Earnings Call Transcript
Positive9-23
The earnings call shows strong financial performance with significant revenue growth, improved margins, and increased cash flow. Product innovation and geographic expansion plans are promising, though they carry some risks. The Q&A section doesn't highlight major concerns, and the market cap suggests moderate volatility. Despite regulatory and competition risks, the overall sentiment is positive due to strong financial metrics and optimistic guidance, suggesting a stock price increase of 2% to 8%.
Clearwater Analytics Holdings, Inc. (CWAN) Presents At Citi's 2025 Global Technology, Media And Telecommunications Conference (Transcript)
Neutral9-15
Clearwater Analytics Holdings, Inc. (CWAN) Q2 2025 Earnings Call Transcript
Positive8-7
The earnings call highlights strong financial performance with a 21% YoY revenue growth projection for Q2 2025 and a 59-61% full-year growth. The Bloomberg partnership and strategic acquisitions support market expansion. The Q&A section reveals positive sentiment, with expectations for accelerated growth and successful cross-selling. Despite management's lack of specificity on some points, the overall outlook is optimistic, especially given the market cap of $4 billion, suggesting a positive stock price movement of 2-8% over the next two weeks.
CWAN Report
Frequently Asked Questions
Where does this earnings call transcript come from?
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
How soon is the transcript available after the earnings call ends?
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
Is the transcript edited or altered in any way?
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
Why do some answers appear as “Unclear” or “Inaudible”?
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
Who creates the AI Summary and Key Q&A highlights shown above the transcript?
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.
